Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumol alleviates liver fibrosis through inducing autophagy and ferroptosis in hepatic stellate cells
Yang Zheng, Tiejian Zhao, Jiaru Wang, et al.
The FASEB Journal (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Iron, Oxidative Stress, and Metabolic Dysfunction—Associated Steatotic Liver Disease
Sophie Gensluckner, Bernhard Wernly, Christian Datz, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 208-208
Open Access | Times Cited: 23
Treatment of liver fibrosis: Past, current, and future
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 6, pp. 755-774
Open Access | Times Cited: 40
Curcumin and Ferroptosis: a Promising Target for Disease Prevention and Treatment
Zahra Foroutan, Alexandra E. Butler, Gökhan Zengin, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 343-349
Closed Access | Times Cited: 9
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 9
Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications
Sicheng Zhai, Rui Wang, Jingyuan Wang, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1659-1704
Closed Access | Times Cited: 8
Research Progress on Sesquiterpenoids of Curcumae Rhizoma and Their Pharmacological Effects
Ting Cui, Boyu Li, Fei Liu, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 387-387
Open Access | Times Cited: 7
Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis
Sen Li, Qian-Jun Ren, Can-Hao Xie, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 15, pp. 2143-2154
Open Access | Times Cited: 6
Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
Le Li, Zhijun Zhu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 14
Anacardic acid improves neurological deficits in traumatic brain injury by anti-ferroptosis and anti-inflammation
Yu Liu, Zongren Zhao, Jianqiang Guo, et al.
Experimental Neurology (2023) Vol. 370, pp. 114568-114568
Open Access | Times Cited: 13
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
JTCD attenuates HF by inhibiting activation of HSCs through PPARα-TFEB axis-mediated lipophagy
Chang Shao, Wen‐Jian Lan, Ying Ding, et al.
Phytomedicine (2025) Vol. 139, pp. 156501-156501
Closed Access
Novel Epitranscriptomic and Epigenetic Therapeutic Strategies and Targets for Ferroptosis in Liver Fibrosis
Minghui Li, Yang Yang, Qi-Qi Dong, et al.
European Journal of Pharmacology (2025) Vol. 996, pp. 177344-177344
Closed Access
Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches
Zhi-Hong Ning, Xiuheng Wang, Yue Zhao, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114341-114341
Closed Access
Natural products modulating MAPK for CRC treatment: a promising strategy
Lin Zhou, Jinlong Zhang, Kangning Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Chinese Medicine for the Treatment of Liver Cirrhosis: The Mechanism of Cellular Autophagy
Shihao Zheng, Tianyu Xue, Qiuyue Wang, et al.
The American Journal of Chinese Medicine (2025), pp. 1-25
Closed Access
New Perspectives on Chinese Medicine in Treating Hepatic Fibrosis: Lipid Droplets in Hepatic Stellate Cells
Chang Shao, Huihui Xu, Xiguang Sun, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 06, pp. 1413-1429
Closed Access | Times Cited: 10
Blueberry anthocyanins improve liver fibrosis by regulating NCOA4 ubiquitination through TRIM7 to affect ferroptosis of hepatic stellate cells
Likun Liu, Jinhui Du, Haiqing Fan, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 326, Iss. 4, pp. G426-G437
Closed Access | Times Cited: 2
Icariin‑curcumol promotes ferroptosis in prostate cancer cells through Nrf2/HO‑1 signaling
Wen S. Sheng, Bonan Li, Tiansong Sun, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 2
Loureirin B ameliorates cholestatic liver fibrosis via AKT/mTOR/ATG7-mediated autophagy of hepatic stellate cells
Wei‐Yi Cheng, Xi-xi Zeng, Ping Cheng, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176552-176552
Closed Access | Times Cited: 2
The connection between autophagy and ferroptosis in AKI: recent advances regarding selective autophagy
Chunyu Pan, Hairui Zhao, Xiaojing Cai, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 2
Ferritinophagy: Molecular Mechanisms and Role in Disease
Qi Zhu, Jianan Zhai, Zhengguo Chen, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155553-155553
Closed Access | Times Cited: 2
ASIC1a regulates ferroptosis in hepatic stellate cells via the Hippo/Yap-1 pathway in liver fibrosis
Yueqin Zhu, Chun Cao, Zihao Li, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113226-113226
Closed Access | Times Cited: 2
Research Progress of Chinese Medicine in Treating Chronic Liver Disease by Regulating Autophagy
Shihao Zheng, Chengyuan Xue, Tianyu Xue, et al.
The American Journal of Chinese Medicine (2024), pp. 1-25
Closed Access | Times Cited: 2
Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
Rui Tang, Jing Luo, Xiaoxia Zhu, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6
Curcumol ameliorates alcohol and high-fat diet-induced fatty liver disease via modulation of the Ceruloplasmin/iron overload/mtDNA signaling pathway
Tingting Ding, Wanqing Shen, Wenhui Tao, et al.
The Journal of Nutritional Biochemistry (2024), pp. 109807-109807
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top